MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program
…, GR Wu, Q Zhou, H Yue, LZ Rao, T Yuan, B Mo… - Science …, 2021 - science.org
Despite past extensive studies, the mechanisms underlying pulmonary fibrosis (PF) still
remain poorly understood. Here, we demonstrated that lungs originating from different types of …
remain poorly understood. Here, we demonstrated that lungs originating from different types of …
Noncoding RNAs in asthmatic airway smooth muscle cells
B Xiao, L Li, D Yao, B Mo - European Respiratory Review, 2023 - Eur Respiratory Soc
Asthma is a complex and heterogeneous airway disease caused by genetic, environmental
and epigenetic factors treated with hormones and biologics. Irreversible pathological …
and epigenetic factors treated with hormones and biologics. Irreversible pathological …
[HTML][HTML] High mobility group box 1: a novel mediator of Th2-type response-induced airway inflammation of acute allergic asthma
L Ma, J Zeng, B Mo, C Wang, J Huang… - Journal of thoracic …, 2015 - ncbi.nlm.nih.gov
Background High mobility group box 1 (HMGB1) is an inflammatory mediator involved into
the advanced stage of systemic inflammatory response syndrome (SIRS), and is over-…
the advanced stage of systemic inflammatory response syndrome (SIRS), and is over-…
[HTML][HTML] LPS enhances TLR4 expression and IFN‑γ production via the TLR4/IRAK/NF‑κB signaling pathway in rat pulmonary arterial smooth muscle cells
P Wang, X Han, B Mo, G Huang… - Molecular medicine …, 2017 - spandidos-publications.com
The aim of the present study was to investigate the role of the Toll‑like receptor (TLR) 4
signaling pathway in cellular response to lipopolysaccharide (LPS) in rat pulmonary artery …
signaling pathway in cellular response to lipopolysaccharide (LPS) in rat pulmonary artery …
[HTML][HTML] Artesunate ameliorates lung fibrosis via inhibiting the Notch signaling pathway
Y Liu, G Huang, B Mo, C Wang - Experimental and …, 2017 - spandidos-publications.com
The present study aimed to determine the underlying molecular mechanism of the antifibrotic
effect of artesunate in pulmonary fibrosis (PF). Primary lung fibroblasts were isolated from …
effect of artesunate in pulmonary fibrosis (PF). Primary lung fibroblasts were isolated from …
[HTML][HTML] Musashi1 as a potential therapeutic target and diagnostic marker for lung cancer
XY Wang, H Yu, RI Linnoila, L Li, D Li, B Mo, H Okano… - Oncotarget, 2013 - ncbi.nlm.nih.gov
Lung cancer remains one of the leading causes of cancer-related deaths worldwide with a 5-year
survival rate of less than 20%. One approach to improving survival is the identification …
survival rate of less than 20%. One approach to improving survival is the identification …
[HTML][HTML] The role of macrophage migration inhibitory factor (MIF) in asthmatic airway remodeling
…, D Yao, B Xiao, H Huang, J Zhang, B Mo - Allergy, asthma & …, 2021 - ncbi.nlm.nih.gov
Purpose Recent studies have demonstrated that macrophage migration inhibitory factor (MIF)
is of importance in asthmatic inflammation. The role of MIF in modulating airway …
is of importance in asthmatic inflammation. The role of MIF in modulating airway …
Diagnostic accuracy of 14‐3‐3 η protein in rheumatoid arthritis: A meta‐analysis
…, G Tang, H Huang, T Yuan, L Rao, B Mo - … journal of rheumatic …, 2020 - Wiley Online Library
Aim To evaluate the overall diagnostic performance of 14‐3‐3 η protein in patients with
rheumatoid arthritis (RA). Methods PubMed, EMBASE, and Web of Science were searched to …
rheumatoid arthritis (RA). Methods PubMed, EMBASE, and Web of Science were searched to …
[HTML][HTML] Elongation factor-2 kinase acts downstream of p38 MAPK to regulate proliferation, apoptosis and autophagy in human lung fibroblasts
Y Wang, G Huang, Z Wang, H Qin, B Mo… - Experimental Cell …, 2018 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a chronic, fatal and progressive fibro-proliferative lung
disease, and fibroblast-to-myofibroblast differentiation is a crucial process in the …
disease, and fibroblast-to-myofibroblast differentiation is a crucial process in the …
[HTML][HTML] Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind …
J Yuan, B Mo, Z Ma, Y Lv, SL Cheng, Y Yang… - Journal of Microbiology …, 2019 - Elsevier
Background/Purpose Nemonoxacin is a novel nonfluorinated quinolone with excellent in vitro
activity against most pathogens in community-acquired pneumonia (CAP), especially Gram…
activity against most pathogens in community-acquired pneumonia (CAP), especially Gram…